Apollomics, Inc.

Getting company information...

Press Releases by Apollomics, Inc.
Filter by year Year
All
2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005

冠科美博（Apollomics Inc.）宣布完成和SPAC Maxpro合并，并在纳斯达克上市

Mar 30, 2023 20:31 HKT/SGT

冠科美博的A类普通股及认股权证预计将于2023年3月30日在纳斯达克资本市场开始交易，股票代码为“APLM”和“APLMW”

冠科美博（Apollomics Inc.）宣佈完成和SPAC Maxpro合併，並在納斯達克上市

Mar 30, 2023 20:30 HKT/SGT

冠科美博的A類普通股及認股權證預計將於2023年3月30日在納斯達克資本市場開始交易，股票代碼為“APLM”和“APLMW”

Apollomics, a Company Developing Novel Oncology Therapies to Address Difficult-to-Treat Cancers, Announces Closing of Business Combination and Listing on Nasdaq

Mar 30, 2023 20:29 HKT/SGT

Apollomics' Class A ordinary shares and public warrants are expected to begin trading today on the Nasdaq Capital Market under the ticker symbols 'APLM' and 'APLMW'

Apollomics, a Company Developing Novel Oncology Therapies to Address Difficult-to-Treat Cancers, Announces Closing of Business Combination and Listing on Nasdaq

Mar 30, 2023 20:05 HKT/SGT

Apollomics' Class A ordinary shares and public warrants are expected to begin trading today on the Nasdaq Capital Market under the ticker symbols 'APLM' and 'APLMW'

冠科美博 (Apollomics Inc.) 扩充其领导团队，任命 Jane Wang 博士担任首席科学官一职

Jul 26, 2022 09:19 HKT/SGT

冠科美博 (Apollomics Inc.) 擴充其領導團隊，任命 Jane Wang 博士擔任首席科學官一職

Jul 26, 2022 09:18 HKT/SGT

Apollomics Inc. Expands Leadership Team with Appointment of Jane Wang, PhD as Chief Scientific Officer

Jul 26, 2022 09:17 HKT/SGT

冠科美博 (Apollomics Inc.) 将于 2022 年 1 月 26-27 日（周三、周四）举办线上投资者活动

Jan 12, 2022 09:27 HKT/SGT

活动将分为英语和中文两场举行，以满足不同时区与会者的需要

冠科美博 (Apollomics Inc.) 將於 2022 年 1 月 26-27 日（週三、週四）舉辦線上投資者活動

Jan 12, 2022 09:26 HKT/SGT

活動將分為英語和中文兩場舉行，以滿足不同時區與會者的需要

Apollomics Inc. to Host Virtual Investor Events on Wednesday, January 26, 2022 and Thursday, January 27, 2022

Jan 12, 2022 09:25 HKT/SGT

English and Chinese Sessions to be Held to Accommodate Multiple Time Zones

冠科美博（Apollomics）首席执行官余国良博士当选为百华协会 (BayHelix Group) 董事会主席

Jan 04, 2022 10:12 HKT/SGT

冠科美博（Apollomics）首席執行官余國良博士當選為百華協會 (BayHelix Group) 董事會主席

Jan 04, 2022 10:11 HKT/SGT

Apollomics Inc. Announces CEO Guo-Liang Yu, PhD Appointed as Chairman of the Board for the BayHelix Group

Jan 04, 2022 10:10 HKT/SGT

冠科美博（Apollomics）Uproleselan 注射液（APL-106）用于治疗复发或难治性急性髓系白血病的中国 III 期临床试验第一例受试者成功入组

Nov 22, 2021 10:42 HKT/SGT

冠科美博（Apollomics）Uproleselan 注射液（APL-106）用於治療復發或難治性急性髓系白血病的中國 III 期臨床試驗第一例受試者成功入組

Nov 22, 2021 10:41 HKT/SGT

Apollomics Inc. Doses First Patient in Phase 3 Clinical Trial with APL-106 (Uproleselan Injection) in Chinese Patients with Relapsed/Refractory Acute Myeloid Leukemia

Nov 22, 2021 10:40 HKT/SGT

Edison Oncology和冠科美博（Apollomics）宣布EO1001(APL-122) I/IIa 期臨床試驗中首例患者接受治療

Oct 01, 2021 10:00 HKT/SGT

Edison Oncology和冠科美博（Apollomics）宣布EO1001(APL-122) I/IIa 期临床试验中首例患者接受治疗

Oct 01, 2021 10:00 HKT/SGT

Edison Oncology and Apollomics Announce Treatment of First Patient by EO1001 (APL-122) in a Phase I/IIa Clinical Trial

Oct 01, 2021 10:00 HKT/SGT

冠科美博（APOLLOMICS）APL-102 中国I期临床研究完成首例患者给药

Aug 10, 2021 11:55 HKT/SGT